SCHEMBL6094245

SCHEMBL6094245

Nc1ccc(O)c(/C=C/C(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.56
▸ CA2 P00918 3/20 0.56
▸ CA4 P22748 3/20 0.56
▸ NFKB1 P19838 2/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.51
▸ KDM4E B2RXH2 6/20 0.50
▸ ALDH1A1 P00352 5/20 0.50
▸ MAPT P10636 5/20 0.50
▸ HSD17B10 Q99714 4/20 0.50
▸ GAA P10253 4/20 0.50
▸ CYP3A4 P08684 3/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ HPGD P15428 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ CYP2C9 P11712 3/20 0.50
▸ THRB P10828 2/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ HIF1A Q16665 2/20 0.50
▸ CA12 O43570 2/20 0.50
▸ CA3 P07451 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6094250 1.00 CA1 (0.56) CA1CA2CA4NFKB1NPSR1
SCHEMBL6095141 0.85 PELI1 (0.54) CA1CA2CA4NFKB1KDM4E
SCHEMBL6095138 0.85 PELI1 (0.54) CA1CA2CA4NFKB1KDM4E
SCHEMBL29763068 0.81 ALDH1A1 (0.64) CA1CA2CA4NFKB1KDM4E
SCHEMBL344639 0.81 ALDH1A1 (0.64) CA1CA2CA4NFKB1KDM4E
SCHEMBL344638 0.81 ALDH1A1 (0.64) CA1CA2CA4NFKB1KDM4E
SCHEMBL9385750 0.80 NPSR1 (0.50) CA1CA2CA4NFKB1NPSR1
SCHEMBL9385744 0.80 NPSR1 (0.50) CA1CA2CA4NFKB1NPSR1
SCHEMBL11823438 0.80 MAPT (0.71) CA1CA2KDM4EALDH1A1MAPT
SCHEMBL3422777 0.79 KDM4E (0.72) CA1CA2CA4NFKB1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7070626-B2 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds WELLA AG (DE) 2006-07-04 — — US disclosed
EP-1286953-B1 (P-AMINO-HYDROXYPHENYL)-ACRYLAMIDE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS WELLA AG (DE) 2004-02-18 — — EP disclosed
US-6635241-B1 Applying aminophenol derivative to keratinous fiber as primary intermediate, oxidizing to color fiber HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2003-10-21 — — US disclosed
US-20030192132-A1 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) 2003-10-16 — — US disclosed
EP-1286953-A1 (P-AMINO-HYDROXYPHENYL)-ACRYLAMIDE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS Wella Aktiengesellschaft (DE) 2003-03-05 — — EP disclosed
WO-2002079144-A1 (P-AMINO-HYDROXYPHENYL)-ACRYLAMIDE DERIVATIVES AND DYES CONTAINING SAID COMPOUNDS WELLA AKTIENGESELLSCHAFT (DE) 2002-10-10 — — WO disclosed
EP-1229891-A1 AGENT FOR COLOURING KERATIN CONTAINING FIBRES Henkel Kommanditgesellschaft auf Aktien (DE) 2002-08-14 — — EP disclosed
WO-2001034105-A1 AGENT FOR COLOURING KERATIN CONTAINING FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-05-17 — — WO disclosed
EP-0883598-A1 AMINOPHENOL DERIVATIVES AND THEIR USE IN OXIDATIVE HAIR DYES Henkel Kommanditgesellschaft auf Aktien (DE) 1998-12-16 — — EP disclosed
WO-1997031886-A1 AMINOPHENOL DERIVATIVES AND THEIR USE IN OXIDATIVE HAIR DYES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1997-09-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030192132-A1 (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds KRT18, ALDH7A1, IK CA1 2675/4885CA2 2352/4885CA4 2539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback